Dietary supplementation of ω-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation

Free Radical Biology and Medicine

Volumn 47, Issue 5, 2009, Pages 622-628

  Yin, Huiyong ^a,b   Liu, Wei ^b   Goleniewska, Kasia ^a   Porter, Ned A ^b   Morrow, Jason D ^a,b   Peebles Jr , R Stokes ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

3 Polyunsaturated fatty acids; Asthma; Fish oil; Free radicals; Isoprostanes; Lung inflammation; Mass spectrometry; Ovalbumin (OVA); Prostaglandins

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 13; INTERLEUKIN 5; ISOPROSTANE DERIVATIVE; OMEGA 3 FATTY ACID; OVALBUMIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG STRUCTURE; FATTY ACID ANALYSIS; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SENSITIZATION; TREATMENT OUTCOME;

ANIMALS; BODY COMPOSITION; CYTOKINES; DIETARY SUPPLEMENTS; DOWN-REGULATION; F2-ISOPROSTANES; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; LIPID METABOLISM; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; OVALBUMIN; PNEUMONIA;

MURINAE;

EID: 67650753496     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.05.033     Document Type: Article

References (65)

1. Wong K.W. Clinical efficacy of n-3 fatty acid supplementation in patients with asthma. J. Am. Diet. Assoc. 105 (2005) 98-105
2. Barnes P.J. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 9 (1990) 235-243
3. Wood L.G., Gibson P.G., and Garg M.L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur. Respir. J. 21 (2003) 177-186
4. Fujisawa T. Role of oxygen radicals on bronchial asthma. Curr. Drug Targets Inflamm. Allergy 4 (2005) 505-509
5. Talati M., Meyrick B., Peebles J.R.S., Davies S.S., Dworski R., Mernaugh R., Mitchell D., Boothby M., Roberts Ii L.J., and Sheller J.R. Oxidant stress modulates murine allergic airway responses. Free Radic. Biol. Med. 40 (2006) 1210-1219
6. Yin H., and Porter N.A. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid. Redox Signal. 7 (2005) 170-184
7. 2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387
8. Morrow J.D., and Roberts L.J. The isoprostanes: Unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36 (1997) 1-21
9. 2-isoprostanes in biological fluids and tissues as measure of oxidant stress. In: Packer L. (Ed). Methods in Enzymology (1999), Academic Press, San Diego, CA 3-12
10. Montuschi P., Barnes P.J., and Roberts II L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 18 (2004) 1791-1800
11. Zanconato S., Carraro S., Corradi M., Alinovi R., Pasquale M.F., Piacentini G., Zacchello F., and Baraldi E. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J. Allergy Clin. Immunol. 113 (2004) 257-263
12. Dworski R., Jackson Roberts Ii L., Murray J.J., Morrow J.D., Hartert T.V., and Sheller J.R. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2). Clin. Exp. Allergy 31 (2001) 387-390
13. Dworski R., Murray J.J., Jackson II R.L., Oates J.A., Morrow J.D., Fisher L., and Sheller J.R. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. evidence for oxidant stress. Am. J. Respir. Crit. Care Med. 160 (1999) 1947-1951
14. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., and Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am. J. Respir. Crit. Care Med. 160 (1999) 216-220
15. Baraldi E., Ghiro L., Piovan V., Carraro S., Ciabattoni G., Barnes P.J., and Montuschi P. Increased exhaled 8-isoprostane in childhood asthma. Chest 124 (2003) 25-31
16. Baraldi E., Carraro S., Alinovi R., Pesci A., Ghiro L., Bodini A., Piacentini G., Zacchello F., and Zanconato S. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 58 (2003) 505-509
17. Tazzeo, T.; Miller, J.; Janssen, L. J. Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle. Br. J. Pharmacol. 140:759-763; 2003.
18. Catalli A., and Janssen L.J. Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2. Am. J. Physiol., Lung Cell Mol. Physiol. 287 (2004) L1035-1041
19. Moore M.L., and Peebles R.S. Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think. J. Allergy Clin. Immunol. 117 (2006) 1036-1039
20. Peebles Jr. R.S., Dworski R., Collins R.D., Jarzecka K., Mitchell D.B., Graham B.S., and Sheller J.R. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am. J. Respir. Crit. Care Med. 162 (2000) 676-681
21. Peebles Jr. R.S., Hashimoto K., Morrow J.D., Dworski R., Collins R.D., Hashimoto Y., Christman J.W., Kang K.-H., Jarzecka K., Furlong J., Mitchell D.B., Talati M., Graham B.S., and Sheller J.R. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in Mice. Am. J. Respir. Crit. Care Med. 165 (2002) 1154-1160
22. Peebles Jr. R.S., Hashimoto K., Sheller J.R., Moore M.L., Morrow J.D., Ji S., Elias J.A., Goleniewska K., O'Neal J., Mitchell D.B., Graham B.S., and Zhou W. Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. J. Immunol. 175 (2005) 8253-8259
23. Zhou W., Newcomb D.C., Moore M.L., Goleniewska K., O'Neal J.F., and Peebles Jr. R.S. Cyclooxygenase inhibition during allergic sensitization increases stat6-independent primary and memory Th2 responses. J. Immunol. 181 (2008) 5360-5367
24. Sturm E.M., Schratl P., Schuligoi R., Konya V., Sturm G.J., Lippe T., Peskar B.A., and Heinemann A. Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J. Immunol. 181 (2008) 7273-7283
25. Kunikata T., Yamane H., Segi E., Matsuoka T., Sugimoto Y., Tanaka S., Tanaka H., Nagai H., Ichikawa A., and Narumiya S. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat. Immunol. 6 (2005) 524-531
26. Chung K.F. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma. Sci. STKE 2005 (2005) pe47
27. Mickleborough T.D., and Rundell K.W. Dietary polyunsaturated fatty acids in asthma- and exercise-induced bronchoconstriction. Eur. J. Clin. Nutr. 59 (2005) 1335-1346
28. Mihrshahi S., Peat J.K., Webb K., Oddy W., Marks G.B., and Mellis C.M. Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatr. Allergy Immunol. 15 (2004) 517-522
29. Prescott S.L., and Calder P.C. N-3 polyunsaturated fatty acids and allergic disease. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 123-129
30. Peat J.K., Mihrshahi S., Kemp A.S., Marks G.B., Tovey E.R., Webb K., Mellis C.M., and Leeder S.R. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J. Allergy Clin. Immunol. 114 (2004) 807-813
31. Almqvist C., Garden F., Xuan W., Mihrshahi S., Leeder S.R., Oddy W., Webb K., and Marks G.B. Omega-3 and omega-6 fatty acid exposure from early life does not affect atopy and asthma at age 5 years. J. Allergy Clin. Immunol. 119 (2007) 1438-1444
32. Mickleborough T.D., Ionescu A.A., and Rundell K.W. Omega-3 fatty acids and airway hyperresponsiveness in asthma. J. Altern. Complement. Med. 10 (2004) 1067-1075
33. Devereux G., and Seaton A. Diet as a risk factor for atopy and asthma. J. Allergy Clin. Immunol. 115 (2005) 1109-1117
34. Nagakura T., Matsuda S., Shichijyo K., Sugimoto H., and Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur. Respir. J. 16 (2000) 861-865
35. Prescott S., and Dunstan J. Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids 42 (2007) 801-810
36. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 (2006) S1505-1519
37. Aoki H., Hisada T., Ishizuka T., Utsugi M., Kawata T., Shimizu Y., Okajima F., Dobashi K., and Mori M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 367 (2008) 509-515
38. Levy B.D., Kohli P., Gotlinger K., Haworth O., Hong S., Kazani S., Israel E., Haley K.J., and Serhan C.N. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178 (2007) 496-502
39. Yin H., Havrilla C.M., Gao L., Morrow J.D., and Porter N.A. Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. "Dioxetane" intermediate versus β-fragmentation of peroxyl radicals. J. Biol. Chem. 278 (2003) 16720-16725
40. 2-isoprostane regioisomers and diastereomers by novel liquid chromatographic/mass spectrometric methods. J. Chromatogr., B 827 (2005) 157-164
41. Porter N., Caldwell S., and Mills K. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30 (1995) 277-290
42. Morrow J.D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 279-286
43. Yin H., Musiek E.S., Gao L., Porter N.A., and Morrow J.D. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J. Biol. Chem. 280 (2005) 26600-26611
44. 4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J. Chromatogr., B 799 (2004) 95-102
45. Quan L.G., and Cha J.K. Preparation of isoprostanes and neuroprostanes. J. Am. Chem. Soc. 124 (2002) 12424-12425
46. 3-isoprostanes) in vivo from eicosapentaenoic acid. J. Biol. Chem. 281 (2006) 14092-14099
47. 2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 300 (1999) 3-12
48. Morrow J., Minton T., Mukundan C., Campbell M., Zackert W., Daniel V., Badr K., Blair I., and Roberts II L. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269 (1994) 4317-4326
49. 2 synthesis in healthy humans and those with lung cancer. Anal. Biochem. 334 (2004) 266-275
50. Hashimoto K., Sheller J.R., Morrow J.D., Collins R.D., Goleniewska K., O'Neal J., Zhou W., Ji S., Mitchell D.B., Graham B.S., and Peebles Jr. R.S. Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms. J. Immunol. 174 (2005) 525-532
51. Cao H., Xiao L., Park G., Wang X., Azim A.C., Christman J.W., and van Breemen R.B. An improved LC-MS/MS method for the quantification of prostaglandins E2 and D2 production in biological fluids. Anal. Biochem. 372 (2008) 41-51
52. Grünig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., Sheppard D., Mohrs M., Donaldson D.D., Locksley R.M., and Corry D.B. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282 (1998) 2261-2263
53. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., and Calder P.C. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur. J. Clin. Invest. 30 (2000) 260-274
54. Sperling R.I., Benincaso A.I., Knoell C.T., Larkin J.K., Austen K.F., and Robinson D.R. Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J. Clin. Invest. 91 (1993) 651-660
55. Gibney M.J., and Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur. J. Clin. Nutr. 47 (1993) 255-259
56. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., and James M.J. The effect on human tumor necrosis factor a and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. (1996) 63
57. Healy D.A., Wallace F.A., Miles E.A., Calder P.C., and Newsholme P. The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35 (2000) 763-768
58. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J., Spur B.W., Robinson D.R., Corey E.J., Lewis R.A., and Austen K.F. Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 312 (1985) 1217-1224
59. Calder P.C. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38 (2003) 343-352
60. 2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin. Exp. Allergy 29 (1999) 1129-1135
61. Hong S., Gronert K., Devchand P.R., Moussignac R.L., and Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278 (2003) 14677-14687
62. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., Hardy M., Gimenez J.M., Chiang N., Serhan C.N., and Bazan N.G. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278 (2003) 43807-43817
63. Mukherjee P.K., Marcheselli V.L., Serhan C.N., and Bazan N.G. Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA 101 (2004) 8491-8496
64. Milne G.L., Yin H., and Morrow J.D. Human biochemistry of the isoprostane pathway. J. Biol. Chem. 283 (2008) 15533-15537
65. 2-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am. J. Respir. Crit. Care Med. 160 (1999) 1947-1951